JP Taparia Height, Weight, Age, Business, Children
By Sebastian Wright
JP Taparia Height, Weight, Age, Business, Children
JP Taparia Height, Weight, Age, Business, Children
JP Taparia is an Indian businessman who is best known as the founder and chairperson of Famy Care Ltd., a Mumbai-based healthcare company that makes hormonal and female reproductive healthcare products. Founded in 1987, the company’s business is focused on offering a wide range of contraceptive options including injectables, oral pills, and condoms. The company is reportedly the biggest producer of Copper-T (an intra-uterine device that is used for birth control and emergency contraception) in the world. According to Forbes magazine, nearly 15% of all the women in the world who use oral contraceptive pills have consumed products from Famy Care Ltd.
Born Name
Jyotiprasad Taparia
Nick Name
JP
JP Taparia as seen in an Instagram Post in April 2026 (Free Press Journal / Instagram)Age
JP Taparia was born in the year 1945.
Born Place
India
Residence
Mumbai, Maharashtra, India
Nationality
Occupation
Businessman
Build
Slim
Height
5 ft 8 in or 173 cm
Weight
69 kg or 152 lbs
JP Taparia (center) with his sons Sanjeev Taparia (left) and Ashutosh Taparia (right), as seen in an Instagram Post in July 2026 (CNBC TV18 / Instagram)Girlfriend / Spouse
Although very few details about his family life are in the public domain, it is well known that JP has 2 sons named Sanjeev Taparia and Ashutosh Taparia – both of whom have served as the managing directors of the family business, Famy Care Ltd.
Race / Ethnicity
Asian (Indian)
Hair Color
Gray
Eye Color
Dark Brown
Sexual Orientation
Straight
Distinctive Features
- Slender frame
- Side-parted, receding hair
- Bespectacled
- Clean-shaven look
- Affable smile
JP Taparia as seen in an Instagram Post in May 2019 (Forbes India / Instagram)JP Taparia Facts
- Born into a family of engineers, JP, until the mid-1980s, was a part of his extended family’s engineering business that specialized in hand tools. In 1987, he founded a healthcare company called Famy Care Ltd. His inspiration was his grandfather who was a first-generation entrepreneur.
- In 1991, the company partnered with Oy Leiras Finland AB, a Finnish wholesaler & distributor of healthcare products. This association helped Famy Care Ltd. become the first company to manufacture contraceptive devices for the healthcare and population control programs being run by the Government of India.
- His sons Sanjeev Taparia and Ashutosh Taparia joined Famy Care Ltd. in 1996 and recognized the need to expand the company’s focus beyond intrauterine devices (IUDs). This led to the development of Mala D, an oral contraceptive that was sold in the form of tablets. It became a widely known and used medication in India and was later on exported to many Asian and African countries.
- In 2016, JP purchased an 11,000 square feet duplex apartment worth INR 60 crores in BKC (Bandra Kurla Complex), a business and residential district in Mumbai, the financial capital of India. It was the then-highest amount of money paid for an apartment in the BKC area.
- In March 2026, the Taparia family, among the highest taxpayers in India, was all over the news after closing the most expensive apartment deal in Indian real estate history. The property, a triplex apartment purchased from the Lodha Group (an Indian multinational real estate company), was worth INR 369 crores and located in Malabar Hill, an upmarket residential neighborhood in South Mumbai.
- The previous record for the most expensive apartment deal in India was held by Niraj Bajaj (the chairman of Bajaj Auto Limited, an Indian multinational automotive manufacturing company that is the world’s 3rd-largest manufacturer of motorcycles and the world’s largest 3-wheeler manufacturer). Niraj had bought a sea-facing duplex apartment worth INR 252.50 crores, also in Malabar Hill.
Featured Image by Free Press Journal / Instagram
- Tags
Did we miss anyone?
RELATED ARTICLES
LEAVE A REPLY
Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here
Current ye@r * Leave this field empty 
Subscribe to our Newsletter
